13:25 - 13:30

A New Local Pre-Operative Diabetes Optimisation Service

Chelsea Henshaw, Foundation Year 2 Doctor, Princess Royal University Hospital

13:31 - 13:36

Are inpatients with hypoglycaemia managed as per Trust and Joint British Diabetes Societies (JBDS) guidance at Aintree University Hospital?

Amirah Husna Binti Noor Azman, Foundation Year 2 Doctor, Aintree University Hospital, University Hospitals of Liverpool Group

13:37 - 13:42

Reducing insulin errors in elderly inpatients with staff education and optimising bedtime snacks.

Amal Puri

13:43 - 13:48

Improving Inpatient Diabetes Care in the Frail Adult : A QIP based on JBDS guidelines(2023)

Varghese Vilangupara Benny, ST4 Specialty registrar in Geriatric Medicine, Nevill Hall Hospital

13:49 - 13:54

Inpatient admissions as opportunities to promote sustainable and safer diabetes care: real-world patterns of insulin pen device use in hospitalised adults

Shreyans Darla, Internal Medicine Trainee/Academic Clinical Fellow, UHB NHS FT/Aston University

13:55 - 14:00

Improving falls prevention through targeted risk assessment and interventions at a tertiary healthcare centre

Annette Loudon, Nursing Manager, Dasman Diabetes Institute

14:01 - 14:06

PenSwitch: a campaign promoting reusable insulin pens for sustainable diabetes care

Bethany Draper, Medical Student, University of Exeter Medical School

14:07 - 14:12

Using Indices of Multiple Deprivation (IMD) to Ensure Equitable Rollout of Hybrid Closed Loop (HCL) Technology Across an Affluent AYA Cohort

Melanie Pritchard, Diabetes Specialist Nurse, University Hospitals Dorset

14:13 - 14:18

Improving Access and Efficiency: Group Education for Initiating GLP1 receptor agonists and GLP1/GIP receptor agonists Therapy

Jacqueline Mc McGillivray, Senior Diabetes Specialist Nurse, NHS Grampian

14:19 - 14:24

Scaling preparedness: using primary care networks to reach Black women with diabetes earlier

Anita Banerjee, ST7 in diabetes / Diabetes registrar, Mersey and West Lancashire teaching hospitals NHS trust

13:25 - 13:40

Transdifferentiation of delta- to beta-cells is increased during mouse pregnancy and is altered by hyperglycemia

David Hill, Senior Scientist, Lawson Research Institute

13:40 - 13:55

Ethinyl estradiol improves glucose homeostasis and modulates pancreatic and gut endocrine function in female ob/ob mice

Ananyaa Sridhar, Research Associate, Ulster University

13:55 - 14:10

Synthetic estrogen exposure alters endometrial responses in streptozotocin-induced diabetic mice

Dawood Khan, Lecturer, Ulster University

14:10 - 14:25

Soluble L-Selectin as an immune marker in type 1 diabetes

Kathleen Gillespie, Professor, University of Bristol

Diabetes UK Nursing and Allied Healthcare Professional Diabetes Research Award

16:15 - 16:20

Service evaluation of an inner London acute NHS trust to determine whether there is equitable access to insulin pumps for people with T1DM

Eva Sheriene Casiechetty, Diabetes Specialist Nurse, St. Georges NHS Hospital Trust

16:21 - 16:26

Can diet and lifestyle education supported by continuous glucose monitoring replace the need for insulin in type 2 patients referred to group start sessions?

Isabelle Harrison, Dietitian, Newcastle upon Tyne Hospitals NHS Foundation Trust

16:27 - 16:32

The reliability of NEWS2 score and White Cell Count in assessing diabetic foot infection

Stephanie Tang, Senior podiatrist, King's College Hospital NHS Foundation Trust

16:33 - 16:38

Impact of neurodivergence on diabetes care and clinical outcomes: A Systematic Review

Thomas Johnston, Diabetes Specialist Nurse, Guy's & St Thomas

16:39 - 16:44

Rising Demand for Inpatient Palliative Care Among Adults with Diabetes in the UK: A 9-Year Retrospective Analysis (2017–2025)

Jason Cheung, Consultant Diabetologist, Norfolk and Norwich University Hospital NHS Foundation Trust

Diabetes UK Primary Care Award

16:45 - 16:50

Progression from normal glucose handling to non-diabetic hypergycaemia – Development and Validation of an Incident Pre-diabetes Prediction Model

Aidan Ines, Chief Data Analyst, Nuffield Health Care

16:51 - 16:56

Managing diabetes mellitus in people with neuroendocrine tumours: pathophysiological insights and treatment approaches.

Muhammad Dr Associate Nizam, Associate Professor, SAPHO / Diabetes UK Aylesbury

16:57 - 17:02

Global guideline target achievements in glycaemic, blood pressure, and lipid control in type 2 diabetes: An updated meta-analysis of 1,618,972 participants

Ghanshyam Kacha, GP/Academic Clinical Fellow, University of Leicester

17:03 - 17:08

Changing pattern of GP referrals: experience from a community diabetes clinic

Jyoti Balani, Consultant Diabetologist, Epsom & St Helier NHS Trust

17:09 - 17:15

Discussion and closing remarks

16:15 - 16:20

Type 1 diabetes risk in UK adults in the general population

Kathleen Gillespie, Professor, University of Bristol

16:21 - 16:26

Lower incidence of type 1 diabetes incidence in South Asian and Black children compared to White children: findings from a UK population-based study

Katie Young, Research Fellow, University of Exeter

16:27 - 16:32

Isle of wight diabetes project- early onset type 2 diabetes. A clinical review of classification leading to 10% reclassification

Hamid Mani, Consultant, Isle of Wight NHS Trust

16:33 - 16:38

Partitioned Polygenic Scores Reveal Mechanistic Heterogeneity in shared T2D and Hypertension Risk

Zhanna Balkhiyarova, Research Fellow, University of Surrey

16:39 - 16:44

Role of physiological measurement of insulin resistance and beta cell function in response variation to oral glucose-lowering therapy: TriMaster trial analysis

Catherine Angwin, Research Fellow, University of ExeterDiabetes UK Primary Care Award

16:45 - 16:50

Isle of wight diabetes project; GLP-1 based therapies drive superior metabolic outcomes in early-onest type 2 diabetes

Jay Saha, Doctor, Queen Alexandra Hospital

16:51 - 16:56

Exploring barriers and facilitators to the initiation of insulin therapy in people with type 2 diabetes from ethnic minority populations

Priscilla Katapa, University of Leicester

16:57 - 17:02

Rare variant analyses reveal lipid and red cell pathways affecting HbA1c accuracy

Camila Armirola Ricaurte, Postdoctoral Research Associate, University of Exeter

17:03 - 17:08

Optimising pre-pregnancy health in women with previous gestational diabetes mellitus on the island of Ireland: A qualitative study

Catherine George, PhD Candidate, Royal College of Surgeons in Ireland

17:09 - 17:15

Discussion and closing remarks

16:15 - 16:30

Islet RGS2 is downregulated in human obesity and CRISPR-Cas9 knock-out renders MIN6 β-cells susceptible to apoptotic stressors

Jessica Starikova, Research Associate, King's College London

16:30 - 16:45

Alyteserin-2a improved glucose tolerance, insulin secretion and insulin sensitivity in mice with diet-induced obesity-diabetes

Opeolu Ojo, Lecturer, University of Wolverhampton

16:45 - 17:00

Identification and validation of novel pancreatic acinar cell populations in type 2 diabetes

Ahmad Al Mrabeh, MRC Career Development Fellow, University of Edinburgh

17:00 - 17:15

Tocotrienol-Rich Fraction Confers Histological Renoprotection in a Type 2 Diabetic Rat Model

Christina Yap, Associate Professor, Monash University Malaysia

17:25 - 17:40

Quantifying Diabetes Stigma in the Inpatient Setting: A Service Evaluation Using SSCI-8

Thazin Wynn, Specialist Registrar, Norfolk & Norwich University Hospital

17:40 - 17:55

The Impact of Blood Pressure Variability and African-Caribbean ethnicity on the Progression of Diabetic Kidney Disease in Type 1 Diabetes

Murat Ozdede, Research Fellow, King's College London

17:55 - 18:10

Evaluating the Impact of Continuous Subcutaneous Insulin Infusion (CSII) on Retinopathy in people with Type 1 Diabetes within the first year of CSII initiation

Xi Tang Wen, Academic Clinical Fellow/IMT2, Norfolk and Norwich University Hospital

18:10 - 18:25

Discussion and closing remarks

17:25 - 17:40

The Diabetic Body: Young Women’s Experiences of Diabetes, Identity, and Body Image

Katie Lamb, Coventry University

17:40 - 17:55

SHIFT: Using conversation cards to build equity awareness in diabetes and pregnancy care

Jade Deacon Cummings, Midwife, Guy’s and St Thomas Hospital NHS Trust

17:55 - 18:10

Real-world Outcomes of Tirzepatide Use in a Diabetes Weight Management Clinic: A Retrospective Observational Study

Raghavendar Palani, ST7, University Hospital Birmingham

18:10 - 18:25

Assessing Resident Doctors' confidence and knowledge in insulin and prescriptions using paper drug charts

Henna Gill, FY2, University Hospitals Sussex

17:25 - 17:40

Physical function in people living with Type 1 Diabetes

Sahar Khodabakhsh, Trial and Project Manager, Leicester Diabetes Centre

17:40 - 17:55

Functional data analysis of postprandial glucose responses to mixed-meals identifies latent phenotypes in Type 1 diabetes with divergent vascular risk profiles

Will Evans, Senior Lecturer Exercise Physiology, University of Sunderland

17:55 - 18:10

High-intensity interval training alters immune response to hypoglycaemia in people with type 1 diabetes and impaired awareness of hypoglycaemia

Catriona Farrell, Clinical Senior Lecturer, University of Dundee

18:10 - 18:25

Experience and acceptability of a reduced-energy whole diet intervention in women with gestational diabetes; A qualitative study of the DiGest trial

Laura Kusinski, Post-doctoral research associate, University of Leicester

9:35 - 9:40

Diabetes 8 care processes done in primary care setting

Esther Afetorgbor, Temple Hill Group

9:41 - 9:46

‘Missingness’ and the person-centred lived experience of diabetes-related amputation: an exploratory scoping review.

Jayne Robbie, Senior Lecturer/Senior Podiatrist, Birmingham City University/University Hospitals Birmingham NHS Trust

9:47 - 9:52

Diabetes in Mental health staff Education (DiME)

Jai Hill, DSN, University Hospitals Dorset

9:53 - 9:58

USING VIRTUAL EDUCATION BUNDLES TO IMPROVE DIABETES-RELATED KNOWLEDGE AMONG NURSING STAFF AT MERSEY & WEST LANCS (MWL) NHS TEACHING HOSPITALS

Natalia Watkinson, Diabetes Specialist Nurse, Mersey and West Lancashire Teaching Hospital

9:59 - 10:04

Improving access to clinical guidance: implementation of a 'Directory of Diabetes' within a secondary care setting

Susan Browne, Diabetes Specialist Nurse, Wirral University Teaching Hospitals Foundation Trust

10:05 - 10:10

Managing difficult conversations and delivering bad news: Communication skills training for podiatry staff in NHS Grampian

Sophie Mohamed, Health Psychologist, NHS Grampian

10:11 - 10:16

Perceptions of Continuous Glucose Monitoring among Patients with Diabetes

Kamal Amoako, Medical Student, University of Plymouth

10:17 - 10:35

Discussion and closing remarks

9:35 - 9:50

A regional diabetes classification hub: 1-year evaluation of a new pathway for classifying early onset type 2 diabetes

Carmel Halevy, Postgraduate Medical Education Fellow, Imperial College Healthcare NHS Trust

9:50 - 10:05

Identifying barriers to effective management of type 2 diabetes in pregnancy: qualitative analysis of a Patient and Public Involvement and Engagement activity

Kyla Fong, PhD student, University of Edinburgh

10:05 - 10:20

Improving Postpartum Diabetes Screening in Women with Gestational Diabetes: Impact of Education and Primary Care Reminders

Jaye Fish, Consultant, Scunthorpe General Hospital

10:20 - 10:35

A national survey to characterise the scope of interventions undertaken to tackle health inequalities in diabetes

Bhavna Sharma, Clinical PhD Student, Imperial College NHS Trust

11:35 - 11:50

Digital education platforms for Type 1 Diabetes: a systematic literature review of clinical, behavioural, and psychosocial outcomes

Nyi Nyi Soe, Student, Edge Hill University

11:50 - 12:05

Development of group education sessions for patients using hybrid closed loop technology: Looping Groups

Lisa Gaff, Specialist Diabetes Dietitian, Addenbrookes Hospital

12:05 - 12:20

Driving Advice for T2DM on Insulin Audit

Harmeet Makan, GPST2, Narborough Road GP Surgery

12:20 - 12:35

Discussion and closing remarks

11:35 - 11:40

Muscarinic receptor antagonists enhance neurite outgrowth in sensory neurons: identifying novel pathways for nerve repair in diabetic neuropathy

Paul Fernyhough, Academic Professor, University of Manitoba

11:41 - 11:46

Single-cell transcriptomics analysis of mouse and human islets identifies GPCR mRNA expression across distinct islet endocrine cell populations.

Zekun Lyu, Post-doctoral Research Associate, King's College London, Guy's Campus

11:47 - 11:52

HDAC6 inhibitors reduce STAT3 activation and signalling in beta cells

Tia Huang, Student, University of Exeter

11:53 - 11:58

Distinct Innate Immune Patterns Accompany Hepatic Necrosis and beta Cell Stress After Intraportal Islet Transplantation in Mice

Angus Comerford, PhD Student, University of Edinburgh

11:59 - 12:04

Metformin and semaglutide decrease microglial metabolic and stress responses under diabetic-like conditions

Natasha Macdonald, PhD Student, University of Exeter

12:05 - 12:10

Ferroptosis in diabetic myopathy

Aysha Ali

12:11 - 12:16

A targeted epi-drug screen identifies HDAC6 inhibition as an enhancer of beta cell function and immune evasion

Steven Millership, Research Fellow, Imperial College London

12:17 - 12:22

Comparative evaluation of INS-1(832/13) and INS-1E cell lines as in vitro models for fatty acid–induced lipotoxicity in type 2 diabetes

Anna Reznik, Student, University of Edinburgh

12:23 - 12:35

Discussion and closing remarks

11:35 - 11:50

Human EndoC βH5 pseudoislets retain glucose sensitivity after prolonged culture and are functional after transplantation into mice

William Blackstone Whines, Research Assistant, Kings College London

11:50 - 12:05

Determining the safe dose of poly(lactic-co-glycolic) acid (PLGA) microparticles for a liver-targeted islet transplantation co-therapy

Sol Olivera, Postdoctoral Research Fellow, University of Edinburgh

12:05 - 12:20

Repurposing of Histone deacetylases (HDAC) inhibitors as a new therapeutic strategy for type 1 diabetes?

Emma Haxton, PhD Student, University of Exeter

12:20 - 12:35

Incretin and apelin receptor co-agonists demonstrate potent insulinotropic and beta-cell protective effects

Finbarr O'Harte, Professor of Endocrinology & Metabolism, Ulster University

13:50 - 14:05

A Systematic Review and Meta-analysis of the relative benefit of dual vs single oral oral hypoglycaemic therapy following diagnosis with type 2 diabetes (T2D)

Adrian Heald/Mairead Kelly

14:05 - 14:20

One-year glycaemic outcomes following total pancreatectomy and islet auto-transplantation: a UK single centre experience

Aleksandra Dunin Borkowska, Resident Doctor, King's College Hospital, Diabetes Department

14:20 - 14:35

Postpartum glucagon-like peptide-1 receptor agonist use is associated with a decreased risk of adverse obstetrical outcomes

Megan Heague, Specialised Foundation Year 2 Doctor, Royal Liverpool University Hospital

14:35 - 14:50

Assessing the Efficacy of Incretin Mimetics on Metabolic Outcomes in Adolescents and Adults with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis

Wajiha Gul

13:50 - 13:55

Next-Gen Diabetic Foot Care: Developing a Virtual MDT Connecting Primary and Secondary Teams

Nadine Price, Consultant in Diabetes and Endocrinology, North East London NHS Foundation Trust

13:56 - 14:01

Things women with gestational diabetes would prefer you didn’t say and what to say instead: findings from a co-design study to produce anti-stigma interventions

Rita Forde, Senior Lecturer, University College Cork

14:02 - 14:07

Retrospective analysis of eligibility for GCK testing in a diabetes antenatal clinic

Jessica Williams, Foundation Y2 doctor, Somerset NHS Foundation Trust

14:08 - 14:13

Improving pre-pregnancy care for women with type 2 diabetes (T2D): do referrals to our secondary care preconception clinic represent our T2D population?

Emily Melon, IMT3, Manchester Foundation Trust

14:14 - 14:19

Number of patients with Type 1 Diabetes achieving HbA1c target of 58mmol/mol or below increased from 18.3% to 33.3% at Aintree University hospital over 5 years

Sabnam Samad, Consultant Physician, Aintree University Hospital

14:20 - 14:25

Economic Value of Continuous Glucose Monitoring: Evidence across Settings and Populations

Mohammed Ahmed, ST7 Diabetes & Endocrinology, The Christie Hospital

14:26 - 14:31

Comparing the utility of the Oral Glucose Tolerance Test in diagnosing gestational diabetes in pregnancy after bariatric surgery

Rajalakshmi Valaiyapathi, Doctor, Imperial College London

14:32 - 14:37

Integrated diabetes and eating disorder care: outcomes of a part-funded trial service for people with type 1 diabetes and disordered eating in North-East London

Sarah Alicea, Doctoral Student & Clinical lead T1DE, University of Warwick / Barts Health

14:38 - 14:50

Discussion and closing remarks

13:50 - 14:05

Anti-inflammatory protection of early vs delayed empagliflozin on monocyte-derived macrophages from patients with type2 diabetes and acute myocardial infarction

Joanna K Ward , PhD Student, University of Lincoln

14:05 - 14:20

Mesenchymal stromal cell secretory peptide cocktail improves stem cell derived islet survival and function

Rosie Sullivan, Research Assistant, King's College London

14:20 - 14:35

Mesenchymal stromal cells (MSCs) promote extracellular matrix (ECM) deposition in reformed islets and improve function

Lydia Daniels Gatward, Research Fellow, King's College London

14:35 - 14:50

Trends in total daily dose and variability of insulin requirements in newly diagnosed children and adolescents with type 1 diabetes (T1D) over 48 months

Chloë Royston, PhD Student, University of Cambridge

Diabetes UK Basic Science Award

15:00 - 15:05

Dysregulated Hippo signalling drives beta cell vulnerability and reveals a novel therapeutic target in type 1 diabetes

Sophia Bigot, PDRA in Pancreatic Islet Biology in Diabetes, Biomedical Institute for Multimorbidity (BIM), Centre for Biomedicine, Hull York Medical School (HYMS), University of Hull

15:06 - 15:11

Mesenchymal stromal cell-derived extracellular vesicles deliver microRNAs to improve islet function

Wen Hong Tzu, Post Doctoral Research Fellow, King's College London

15:12 - 15:17

Do the small things matter? The relationship between pancreas development post-birth and Type 1 Diabetes disease heterogeneity

Teifion Luckett, Postdoctoral Research Associate, University of Exeter

15:18 - 15:23

M6PR controls insulin secretion and incretin responses by protecting β-cell lysosomal function

Rosa Alen, Research Associate, Section of Cell Biology and Functional Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London

15:24 - 15:29

Proinflammatory cytokine stress leads to PC1/3-driven GLP-1 production from alpha-cells and delta-cell GLP-1R upregulation in rodent islets.

Hannah Abdu, Student, University of Oxford

Diabetes UK Clinical Science Award

15:30 - 15:35

Isle of wight diabetes project; structured tabletop review and treatment optimisation improves glycemic category in early onset type 2 diabetes

George Gavoyannis, FY1 Doctor, Isle of Wight NHS Trust

15:36 - 15:41

Precision medicine in type 2 diabetes: Expansion of a 5-drug class treatment selection model to include Semaglutide

Pedro Cardoso, Research Associate, University of Exeter

15:42 - 15:47

Progression to type 2 diabetes postpartum and 15-year vascular outcomes

Sahana Mahesh, Foundation Doctor, University Hospitals Liverpool Group

15:48 - 15:53

Novel blood protein biomarkers robustly discriminate Type 1 Diabetes from Type 2 Diabetes

Kashyap Patel, Associate Professor, University of Exeter

15:54 - 15:59

Deploying genetic risk scores for type 1 and type 2 diabetes to aid classification of diabetes in early-onset lean diabetes

Raymond Win, Doctoral Fellow, Imperial College London

15:00 - 15:05

Co-developing Carer Leaflet and HCP Training Using ADAPT to Support Eating Disorder Prevention in Welsh Paediatric Diabetes Care

Aisling Pigott, Doctoral Researcher, Cardiff Metropolitan University

15:06 - 15:11

From Screening to Strategy: Using Annual Psychology Screening Data to Drive Service Innovation in Paediatric Diabetes Care

Sarah Cook, Clinical Psychologist, Dorset County Hospital Foundation Trust

15:12 - 15:17

Addressing Psychological Needs in Type 1 Diabetes: Improving Uptake of Diabetes Distress Scale-2 Screening in a District General Hospital

Pallavi Agarwal, Specialty Doctor, Guy's and St Thomas NHS Foundation Trust

15:18 - 15:23

Process Evaluation of Patient & Public Involvement in the D-stress Study: Intervention Development for Diabetes Distress

Jennifer Mohammadi, Research Assistant & PhD Student, King's College London

15:24 - 15:29

Using genetics to understand the role of lifestyle and socioeconomic factors in the relationship between Major Depressive Disorder and Type 2 Diabetes

Renu Bala, Postdoctoral Research Associate, University of Exeter

15:30 - 16:00

Discussion and networking

17:00 - 17:15

Mortality and Stroke Outcomes of SGLT2 Inhibitor Use in Older Adults With Type 2 Diabetes According to Frailty status:A Real-World Population-Based Cohort Study

Rami Aldafas

17:15 - 17:30

A novel glucose beta-hydroxybutyrate (BHB) combination improves hypoglycaemia recovery and patient-reported outcomes in type 1 diabetes

David Russell Jones, Prof of Diabetes & Endocrinology, Royal Surrey Foundation Trust

17:30 - 17:45

A variant in PIEZO1 carried by ~8% of South Asians is associated with delayed prediabetes and diabetes diagnosis and may increase diabetic eye disease risk

Samuel Miriam, Academic GP, Queen May University London

17:45 - 18:00

Clinical frailty is a key determinant of survival in people with a diabetic foot ulcer: Implications for management?

Nicola Andrzejowska, Medical Student, Sheffield Teaching Hospitals

17:00 - 17:15

Wenjun Wang, PhD student, Department of Diabetes, School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia

17:15 - 17:30

Kieran Smith, Postdoctoral researcher, University of Oxford

17:30 - 17:45

Jana Soenksen, Postdoctoral Research Associate, University of Exeter

17:45 - 18:00

Andrew Mason , Postdoc, University of Liverpool

17:00 - 17:15

A case of lactation-associated euglycaemic ketoacidosis in a patient with Type 1 diabetes

Maria Omer, Doctor, Countess of Chester Hospital

17:15 - 17:30

Unmasking Acquired Lipodystrophy Type 6: A Rare Culprit Behind Extreme Insulin Resistance

Hafiz Hamza Zubair, IMT2, Nottingham University Hospitals

17:30 - 17:45

Early detection of Type 1 diabetes autoimmunity in a person with Type 2 diabetes and metabolic complications

Kerrie Thackray, Consultant Physician in Diabetes and Endocrinology, Singapore General Hospital

17:45 - 18:00

Conundrums in diabetes presentation: A dual diagnosis of Maternally Inherited Diabetes and Deafness (MIDD) and Latent Autoimmune Diabetes in Adults (LADA)

Farah Anwar, SHO, Department of Diabetes and Endocrinology, Salford Royal Hospital, Northern Care Alliance NHS foundation Trust

Diabetes UK Paediatric Diabetes Award

09:00 - 09:05

Improving Clinic Outcomes in a Young Person Diabetes Clinic by reducing DNA (Did not Attend) rates in an Under-Resourced South London District General Hospital  

Aarthi Surendran, Consultant, Lewisham and Greenwich NHS trust

09:06 - 09:11

Equity in Action: How dedicated roles Improved technology access for Children and Young People across ethnicity and deprivation. 

Nikki Dawson, PDSN - Lead, North West Anglia NHS Foundation Trust

09:12 - 09:17

A quest for control in the face of the unknown - exploring parents’ response to paediatric presymptomatic type 1 diabetes diagnosis 

Lauren Quinn

Diabetes UK Young People's Diabetes Service Award

09:18 - 09:23

Transforming Diabetes Eye Screening Uptake in Young Adults in a High-Deprivation Setting 

Amit Banerjee, ST7 in Diabetes / Diabetes Registrar, Mersey and West Lancashire teaching hospitals NHS trust

09:24 - 09:29

Evidencing the impact of psychological intervention in the young adult diabetes service

Anne Hilder, Principal Psychotherapist, Liverpool University Hospitals NHS Foundation Trust

09:30 - 09:35

Reducing Ethnic Inequalities in Diabetes Technology Uptake Through a Targeted Young Adult Pathway in a Diverse, Urban Population

Myuri Moorth, Diabetes Consultant, Barts Health

09:36 - 09:41

Target trial emulations of GLP-1/GIP receptor agonists to prevent adverse pregnancy outcomes in nulliparous patients with early-onset type 2 diabetes 

Phoebe Holmes

09:42 - 09:47

Atypical Gestational Diabetes as an indicator of subclinical Type 1 Diabetes 

Nhan Dinh, Medical Student, Imperial College London

09:48-10:00

Discussion and closing remarks

09:00 - 09:05

Management Pitfalls of Diabetes Ketoacidosis in patients with Chronic Kidney Disease on Dialysis

Pyar Yu Kyi, ST7 Trainee, The University Hospital of North Midlands

09:06 - 09:11

Understanding patient practise: real-world insulin self-management in children and young people with type 1 diabetes

Karen Rigby, PhD Student, University of Bristol

09:12 - 09:17

Finding MODY: Redefining Diabetes and Unlocking Personalized Care within a Young Adult Service (Maturity-Onset Diabetes of the Young project)

Prethivan Gopalakrishnan, Higher Specialty Trainee in Diabetes & Endocrinology, Royal Liverpool University Hospital

09:18 - 09:23

Use of C peptide and Diabetes antibody screen for the classification of diabetes: our experience within a secondary care diabetes clinic

Scott Williams, Consultant Diabetes and Endocrinology, Countess of Chester Hospital

09:24 - 09:29

Incidence of diabetes in women with and without a history of breast cancer: a matched population-based cohort study using electronic health records.

Harriet Daultrey, Academic Clinical Lecturer, Brighton and Sussex Medical School

09:30 - 09:35

Current NICE guidelines for pancreatic cancer screening have poor performance in newly diagnosed suspected type 1 and type 2 diabetes

Daisy Cavendish, 2nd year Medical Student, University of Exeter

09:36 - 09:41

Effectiveness of Oral Semaglutide in a Primary Care setting in the United Kingdom: a Clinical Practice Research Datalink study

Edward Jude

09:42 - 09:47

Weight Changes Following Continuous Glucose Monitoring Initiation in Adults with Type 1 Diabetes: A Nationwide Analysis in Scotland, 2017-2023

William Berthon, Health Data Scientist / Epidemiologist, The University of Edinburgh

09:48 - 09:53

Bridging the gap between screening and care: real-world experience from a national early-stage type 1 diabetes clinic in the UK

Theodora Papanikolaou, Clinical Research Fellow, Paediatrician, Institute of Immunology and Immunotherapy, University of Birmingham

09:54 - 10:00

Discussion and closing remarks

9:00 - 9:15

Structured High HbA1c Pathway: Innovation, Equity, and Transformation in Young Adult Diabetes Care

Tala Balafshan, Diabetes and Endocrinology Consultant, Mersey and West Lancashire Teaching Hospital NHS Trust

9:15 - 9:30

Quality improvement for type 1 diabetes care in resource constrained remote settings:  A data driven approach

Sam Philip, Consultant Diabetologist, NHS Grampian

9:30 - 9:45

Glycaemic outcomes in patients naïve to hybrid closed loop insulin pump therapy in a deprived urban population

Imola Ryan, Diabetes Specialist Nurse, Barts Health NHS Trust

9:45 - 10:00

Discussion and closing remarks